Pulmonary complications of leptospirosis

Clinics in Chest Medicine

Volumn 23, Issue 2, 2002, Pages 469-478

  Carvalho, Carlos Roberto Ribeiro ^a   Bethlem, Eduardo P ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DOXYCYCLINE; PENICILLIN G; TETRACYCLINE;

BRAZIL; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; HUMAN; HUMAN TISSUE; INFECTION PREVENTION; LEPTOSPIRA; LEPTOSPIROSIS; LUNG DISEASE; MORTALITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; BACTERIAL PNEUMONIA; MICROBIOLOGY;

HUMAN; LEPTOSPIROSIS; PNEUMONIA, BACTERIAL; HUMANS;

EID: 0036086269     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(01)00010-7     Document Type: Review

References (68)

1. Leptospira species
2. Leptospirosis in Latin America
3. Leptospirosis
4. Differentiation of Leptospira interrogans isolates by IS1500 hybridization and PCR assays
5. Pulmonary leptospirosis
6. Veber eine eigenthumliche, milmilztumor, icterus and nephritis einhergehende, acute infection-skrankheit
7. Antibiotics for preventing leptospirosis
8. Leptospirosis
9. Human leptospirosis
10. Antibiotics for leptospirosis
11. Contribuição ao conhecimento da epidemiologia da leptospirose humana com especial referência ao Grande Rio, Brasil, de 1970 a 1982
12. Leptospirosis
13. Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995
14. Emerging infectious diseases and risk to the traveler
15. Graphs and maps for selected notifiable diseases in the United States
16. Graphs and maps for selected notifiable diseases in the United States, 1993
17. Active surveillance and risk factors for leptospirosis in Hawaii
18. Outbreak of leptospirosis with pulmonary involvement in north Andaman
19. Vascular damage in acute experimental leptospirosis of the guinea pig
20. The pathogenesis of leptospirosis: Toxin productions by Leptospira icterohaemorrhagiae
21. Cardiovascular involvement in human and experimental leptospirosis: Pathologic findings and immunohistochemical detection of leptospiral antigen
22. Studies on the interactions between macrophages and leptospires
23. Glycolipoprotein cytotoxin from Leptospira interrogans serovar copenhageni
24. Leptospiral antigen in the kidney of experimentally infected guinea pigs and their relation to the pathogenesis of renal injury
25. Phospholipase activity and virulence of pathogenic leptospirae
26. Lung lesions in human leptospirosis: Microscopic, immunohistochemical, and ultrastructural features related to thrombocytopenia
27. Leptospirosis complicated by a Jarisch-Herxheimer reaction and adult respiratory distress syndrome: Case report
28. Human leptospirosis
29. Morphological characterization of lung and kidney lesions in C3H/HeJ mice infected with Leptospira interrogans serovar icterohaemorrhagiae: Defect of CD4+ and CD8+ T-cells are prognosticators of the disease progression
30. Leptospirose humana. Breves considerações a propósito de uma casuística
31. Pulmonary manifestations of leptospirosis
32. Respiratory manifestations of leptospirosis. A retrospective study of 91 cases (1978-1984)
33. Risk factors for death and changing patterns in leptospirosis acute renal failure
34. Leptospirosis: Prognostic factors associated with mortality
35. Clinico-epidemiological study of hospitalized cases of severe leptospirosis
36. Leptospirosis of the lung: Radiographic findings in 58 patients
37. The chest radiograph in leptospirosis in Jamaica
38. Hemoptises e sindrome de angústia respiratória do adulto como causas de morte na leptospirose. Mudanças de padr̃oes clinicos e anatomopatológicos
39. Comprometimento pulmonar na leptospirose
40. Comprometimento pulmonar na leptospirose
41. Assessment of the efficacy of an IgM-Elisa and microscopic agglutination test (MAT) in the diagnosis of acute leptospirosis
42. Bronchoalveolar lavage in rapid diagnosis of leptospirosis
43. Lung manifestations in leptospirosis
44. Pulmonary manifestations of leptospirosis
45. Studies on anicteric leptospirosis. III. Roentgenologic observations of pulmonary changes
46. Cardiac and pulmonary involvement in leptospirosis
47. Pulmonary haemorrhage as a predominant cause of death in leptospirosis in Seychelles
48. Pulmonary involvement in leptospirosis
49. Acute lung injury in leptospirosis: Clinical and laboratory features, outcome, and factors associated with mortality
50. Unilateral leptospiral pneumonia and cold agglutinin disease
51. Effect of a lung protective approach on mortality in the acute respiratory distress syndrome
52. Adult respiratory distress syndrome in Leptospira icterohaemorrhagiae infection
53. Adult respiratory distress syndrome in Thai medical patients
54. Adult respiratory distress syndrome in Leptospira canicola infection
55. Clinical, radiological and functional pulmonary manifestations in patients with leptospirosis
56. Etats de choc au cours des Leptospiroses ictero-hemorragiques. Quatre observations
57. Cardiac involvement in severe leptospirosis
58. Studies on anicteric leptospirosis. II. Observations on electrocardiograms
59. New uses of older antibiotics
60. The role of pathology in studies of emerging infectious diseases associated with acute respiratory distress syndrome
61. Protective ventilation for the acute respiratory distress syndrome
62. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
63. Beneficial effects of the "open lung approach" with low distending pressures in acute respiratory distress syndrome
64. Temporal hemodynamic effects of permissive hypercapnia associated with "ideal PEEP" in ARDS
65. Massive pulmonary haemorrhage caused by leptospirosis succesfully treated with nitric oxide inhalation and haemofiltration
66. Current opinion in infectious disease